Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFABUTIN vs RIFAMPIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFABUTIN vs RIFAMPIN: Safety Overview

Metric RIFABUTIN RIFAMPIN
Total FAERS Reports 1,586 13,347
Deaths Reported 158 1,439
Death Rate 10.0% 10.8%
Hospitalizations 502 5,764
Average Patient Age 53.2 yrs 51.7 yrs
% Female Patients 53.1% 47.8%
FDA Approval Date Dec 17, 2021 Approved Prior to Jan 1, 1982
Manufacturer REMEDYREPACK INC. Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued